May 16, 2022
Rare Disease Drug Developers Face Bear Market in April
Read More
May 16, 2022
Kriya Raises $270 Million to Advance Fully Integrated Gene Therapy Engine
Read More
May 10, 2022
MOMA Therapeutics Raises $150 Million to Advance Precision Oncology Programs
Read More
May 10, 2022
Blade Therapeutics Reverse Merges with SPAC to Become Public Company
Read More
May 6, 2022
PepGen Raises $108 Million in IPO to Advance Neuromuscular Disease Pipeline
Read More
May 5, 2022
Pliant Enters into $100 million Loan Facility with Oxford Finance to Support Development of IPF Therapy
Read More
May 3, 2022
Dianthus Launches with $100 Million to Develop Antibody Complement Therapeutics
Read More
May 2, 2022
Rezolute Raises $130 Million on Heels of Positive Phase 2 Study of RZ358 in Patients with Congenital Hyperinsulinism
Read More
May 2, 2022
Genome Insight Raises $23 Million to Advance Whole Genome Sequencing Analysis
Read More
May 2, 2022
Virica Enters Collaboration with the Government of Canada
Read More
April 29, 2022
Belite Bio Prices $36 Million Initial Public Offering
Read More
April 28, 2022
Kelonia Launches with $50 Million to Pioneer Precision Targeted Genetic Medicines
Read More
Load More
X